$9,01
▼ $-0,09
(-0,99%)
Vol 135K
5
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$186.1M
ROE
-84,5%
Margin
-93,0%
D/E
102,91
Beta
1,23
52W
$4–$19
Konsensus Wall Street
13 analis · Apr 20263
Beli Kuat
8
Beli
1
Tahan
1
Jual
0
Jual Kuat
84,6%
Peringkat Beli
Grafik Harga
Saham Serupa
Pendapatan
Tingkat beat: 50,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $-0,45 | $-0,46 | $-0,01 |
| Sep 2025 | $-0,51 | $-0,49 | +$0,02 |
| Jun 2025 | $-0,53 | $-0,57 | $-0,04 |
| Mar 2025 | $-0,58 | $-0,53 | +$0,05 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Pendapatan | $15.3M | $12.3M | $13.6M | $14.7M | $16.0M |
| Laba Bersih | -$10.7M | -$13.8M | -$14.7M | -$12.9M | -$11.9M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -79.3% | -79.3% | -79.3% | -79.3% | -84.5% | -84.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -108.4% | -95.6% | -95.6% | -95.6% | -93.0% | -93.0% |
| Gross Margin | 84.3% | 83.5% | 83.5% | 83.5% | 84.5% | 84.5% |
| D/E Ratio | 85.26 | 85.26 | 85.26 | 85.26 | 102.91 | 102.91 |
| Current Ratio | 11.99 | 11.99 | 11.99 | 11.99 | 9.62 | 9.62 |
Rasio Utama
ROA (TTM)
-42,1%
P/S (TTM)
3,32
P/B
4,3
EPS (TTM)
$-2,02
CF/Share
$-2,03
Pertumbuhan Pendapatan 3T
+57,9%
52W High
$18,55
52W Low
$4,30
$4,30
Rentang 52 Minggu
$18,55
Kesehatan Keuangan
Arus Kas Bebas
-$9.8M
Utang Bersih
-$25.2M
Kas
$75.7M
Total Utang
$50.5M
Per tanggal Des 31, 2025
Як CVRX виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка CVRX vs аналоги Health Care
P/E
—
▼
0%
di bawah
rekan
(30,7)
vs Rekan
vs Industri
Undervalued
P/S
3,3
▲
29%
di atas
rekan
(2,6)
vs Rekan
vs Industri
Lebih mahal
P/B
4,3
▲
56%
di atas
rekan
(2,8)
vs Rekan
vs Industri
Lebih mahal
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,7%)
vs Rekan
vs Industri
Yield rendah
Прибутковість CVRX vs аналоги Health Care
ROE
-84,5%
▼
119%
di bawah
rekan
(-38,5%)
vs Rekan
vs Industri
Lemah
Net margin
-93,0%
▼
276%
di bawah
rekan
(-24,7%)
vs Rekan
vs Industri
Lemah
Валова маржа
84,5%
▲
60%
di atas
rekan
(52,9%)
vs Rekan
vs Industri
Tingkat atas
ROA
-42,1%
▼
98%
di bawah
rekan
(-21,2%)
vs Rekan
vs Industri
Lemah
Фінансове здоровʼя CVRX vs аналоги Health Care
D/E ratio
102,9
▲
434%
di atas
rekan
(19,3)
vs Rekan
vs Industri
Utang tinggi
Поточна ліквідність
9,6
▲
345%
di atas
rekan
(2,2)
vs Rekan
vs Industri
Likuiditas kuat
Beta
1,2
▲
17%
di atas
rekan
(1,1)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів CVRX
CVRX
Median rekan
Industri
CVRX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
CVRX vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
HYKES KEVIN
Chief Executive Officer · Mar 02
7763 shs
VERRASTRO PAUL
Officer · Mar 02
1284 shs
OASHEIM JARED
Chief Financial Officer · Mar 02
1744 shs
JOHN ROBERT ALLEN
Officer · Mar 02
3964 shs
ADAMSON PHILIP B.
Officer · Mar 02
1262 shs
MORRISON GREGORY
Officer · Mar 02
34000 shs
HYKES KEVIN
Chief Executive Officer · Feb 27
159000 shs
BINKOWSKI BRENT
Chief Operating Officer · Feb 27
15000 shs
VERRASTRO PAUL
Officer · Feb 27
45000 shs
OASHEIM JARED
Chief Financial Officer · Feb 27
61000 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 35,12%Johnson & Johnson
15,30%
$35.9M
NEA Management Company, LLC
7,70%
$18.1M
Vanguard Group Inc
4,26%
$10.0M
Blackrock Inc.
4,03%
$9.5M
GSK plc
3,83%
$9.0M
Per tanggal Des 31, 2025
Berita Terbaru
Belum ada berita terkait